Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote ER in Adolescent Migraine
NCT00195741Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of divalproex sodium in migraine (4 arms), sponsored by Abbott Laboratories. Primary endpoint: Reduction from baseline in 4-week migraine headache rate. Started May 2003; status: completed.
02
Drugs
divalproex sodium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00195741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195741.